Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism

European Journal of Pharmacology

Volumn 465, Issue 1-2, 2003, Pages 115-123

  Bradamante, Silvia ^a   Barenghi, Livia ^a   Piccinini, Franco ^a   Bertelli, Alberto A E ^a   De Jonge, Robert ^b   Beemster, Patricia ^b   De Jong, Jan Willem ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

(Rat); 31P NMR (nuclear magnetic resonance); Adenosine; Ischemia, low flow; Preconditioning

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RESVERATROL; TAP WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; DRUG MECHANISM; HEART; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; LONG TERM CARE; MALE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; VASODILATATION;

EID: 0037470756     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01441-9     Document Type: Article

References (37)

1. Arichi H., Kimura Y., Okuda H., Baba K., Kozawa M., Arichi S. Effects of stilbene components of the roots of polygonum on lipid metabolism. Chem. Pharm. Bull. 30:1982;1766-1770.
2. 1 receptor triggered) preconditioning; is eNOS masquerading as iNOS? Cardiovasc. Res. 53:2002;405-413.
3. Bertelli A.A., Giovannini L., Giannessi D., Migliori M., Bernini W., Fregoni M., Bertelli A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tissue React. 17:1995;1-3.
4. Bertelli A.A.E., Giovannini L., Stradi R., Bertelli A., Tillement J.-P. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tissue React. 18:1996;67-71.
5. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell. Cardiol. 33:2001;1897-1918.
6. Bradamante S., De Jong J.W., Piccinini F. Intracellular magnesium homeostasis is involved in the functional recovery of preconditioned rat heart. Biochem. Biophys. Res. Commun. 196:1993;872-878.
7. Bradamante S., Piccinini F., Delu C., Janssen M., de Jong J.W. NMR evaluation of changes in myocardial high energy metabolism produced by repeated short periods of ischemia. Biochim. Biophys. Acta. 1243:1995;1-8.
8. Bradamante S., Piccinini F., Barenghi L., Bertelli A.A.E., De Jonge R., Beemster P., De Jong J.W. Does resveratrol induce pharmacological preconditioning? Int. J. Tissue React. 22:2000;37-40.
9. Bunger R., Mukohara N., Kang Y.H., Mallet R.T. Combined glyceraldehyde-3-phosphate dehydrogenase/phosphoglycerate kinase in catecholamine-stimulated guinea-pig cardiac muscle. Comparison with mass-action ratio of creatine kinase. Eur. J. Biochem. 202:1991;913-921.
10. Chan M.M.-Y., Mattiacci J.A., Hwang H.S., Shah A., Fong D. Synergy between ethanol and grape polyphenols, quercitin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem. Pharmacol. 60:2000;1539-1548.
11. Chen C.K., Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated aorta. Gen. Pharmacol. 27:1996;363-366.
12. Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron. Artery Dis. 8:1997;645-649.
13. Daly J.W., Padgett W., Shamim M.T., Butts-Lamb P., Walters J. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonist for A1- and A2-adenosine receptor. J. Med. Chem. 28:1985;482-487.
14. De Jonge R., de Jong J.W., Giacometti D., Bradamante S. Role of adenosine in ischemic preconditioning of rat hearts. Eur. J. Pharmacol. 414:2001;55-62.
15. Flaherty J.T., Weisfeldt M.L., Bulkley B.H., Gardner T.J., Gott V.L., Jacobus W.E. Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation. 65:1982;561-570.
16. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL oxidation by resveratrol. Lancet. 341:1993;1103-1104.
17. Fremont L. Biological effects of resveratrol. Life Sci. 66:2000;663-673.
18. Guo Y., Jones W.K., Xuan Y.T., Tang X.L., Bao W., Wu W.J., Han H., Laubach V.E., Ping P., Yang Z., Qiu Y., Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11507-11512.
19. Headrick J.P. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J. Mol. Cell. Cardiol. 28:1996;1227-1240.
20. Hsieh T.C., Juan G., Darzynkiewicz Z., Wu J.M. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59:1999;2596-2601.
21. Hung L.-M., Chen J.-K., Huang S.-S., Lee R.-S., Su M.-J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47:2000;549-555.
22. Jacobson K.A., van Galen P.J., Williams M. Adenosine receptor: pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem. 35:1992;407-422.
23. Jayatilake G.S., Jayasuriya H., Lee E.S., Koonchanok N.M., Geahlen R.L., Ashendel C.L., McLaughlin J.L., Chang C.J. Kinase inhibitors from Polygonum cuspidatum. J. Nat. Prod. 56:1993;1805-1810.
24. Kimura Y., Okuda H., Arichi S. Effects of stilbene derivatives on arachidonate metabolism in leukocytes. Biochim. Biophys. Acta. 837:1985;209-212.
25. Ragazzi E., Froldi G., Fassina G. Resveratrol activity on guinea pig isolated trachea from normal and albumin-sensitized animals. Pharmacol. Res. Commun. 20:1988;79-82.
26. Ray P.S., Maulik G., Cordis G.A., Bertelli A.A.E., Bertelli A., Das D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic. Biol. Med. 27:1999;160-169.
27. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
28. Renaud S.C., Gueguen R., Schenker J., d'Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology. 9:1998;184-188.
29. Rotondo S., Rajtar G., Manarinis S., Celardo A., Rotillo D., de Gaetano G., Evangelista V., Cerletti C. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J. Pharmacol. 123:1998;1691-1699.
30. Smits P., Williams S.B., Lipson D.E., Banitt P., Rongen G.A., Creager M.A. Endothelial release of NO contributes to the vasodilator effect of adenosine in humans. Circulation. 92:1995;2135-2141.
31. Smolenski R.T., Lachno D.R., Ledingsham S.J., Yacoub M.H. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J. Chromatogr. 527:1990;414-420.
32. Soleas G.J., Yan J., Goldberg D.M. Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection. Methods Enzymol. 335:2001;130-145.
33. Soleas G.J., Angelini M., Grass L., Diamandis E.P., Goldberg D.M. Absorption of trans-resveratrol in rats. Methods Enzymol. 335:2001;145-154.
34. Stumpe T., Ulrich K.M., Decking M., Schrader J. Nitric oxide reduces energy supply by direct action on the respiratory chain in isolated cardiomyocytes. Am. J. Physiol. 280:2001;H2350-H2356.
35. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ. Res. 88:2001;520-528.
36. 2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br. J. Pharmacol. 109:1993;424-429.
37. Zhao T., Xi L., Chelliah J., Levasseur J.E., Kukreja R.C. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice. Circulation. 102:2000;902-907.